IVIS® Imaging Systems - Identify Pathways, Monitor Diseases
Sign up for our IVIS User Group Meeting on Tuesday, September 9th and Wednesday, September 10th in Nice, France (in conjunction with SMI)!
With the acquisition of Xenogen Corporation in 2006, Caliper became the world leader in in vivo optical imaging. Combining strengths in both physics and biology, IVIS® Imaging technology provides the most sensitive imaging systems in the market - for both fluorescence and bioluminescence. IVIS molecular imaging systems are designed to enable researchers to identify disease pathways, determine mechanisms of action, evaluate efficacy of drug compounds, and monitor lead candidates' effects on disease progression in living animals - making in vitro to in vivo translational research a reality.
In addition to a wide range of imaging systems, Caliper offers a large array of imaging tools and reagents to further facilitate drug discovery and development efforts. These include luciferin, fluorescent and bioluminescent labeling kits, light producing cell lines & microorganisms tagged with luciferase gene constructs and light producing animal models which are genetically engineered to emit light when a specific gene is activated.
For more information on Caliper's IVIS imaging systems please fill out the
Product & Services Inquiry Form
or contact David Panzarella at +1-845-735-1921 or David.Panzarella@caliperls.com.
